skip to main | skip to sidebar

Afrezza

AFREZZA™ is a novel, ultra rapid acting mealtime insulin therapy by Mannkind Corporation. Visit Mannkind's official website www.mannkindcorp.com for more information;

  • Site Map
  • Home
  • Afrezza
  • Mannkind
  • Analysts
  • CEO
  • Stock
  • Physicians
  • Patients
  • News
  • Report

Friday, November 23, 2012

Big Sugar's Sweet Little Lies

 

Great article from Mother Jones

http://www.motherjones.com/print/197151

Email ThisBlogThis!Share to TwitterShare to Facebook
Links to this post
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

Search This Blog

Loading...

Interviews with management

  • Interview with Alfred E. Mann - June-2010
  • Al Mann speech at Johns Hopkins - 2010 (new)
  • Al Mann speech at OCR - 2010 (new)
  • Fox news video on inhaled insulin
  • Pete Richardson - Clip syndicate video
  • MannKind's CFO Pfeffer Upbeat on Afresa's Future
  • Interview with Dr Andrea Leone Bay
  • Hakan interview - may 26-2010

MNKD Quick quote

Upcoming events

Afrezza

Completion of pt enrollment in Studies 171 and 174 - 2Q12
Completion of Studies 171 and 174 - YE12
Results of Studies 171 and 174 - Late 2012/1Q13
Re-submission to FDA - 1H13
Potential 3rd PDUFA - 4Q13

Subscribe To Afrezza blog

Posts
Atom
Posts
All Comments
Atom
All Comments

Blog Archive

  • ►  2013 (7)
    • ►  May (3)
    • ►  March (3)
    • ►  January (1)
  • ▼  2012 (24)
    • ▼  November (1)
      • Big Sugar's Sweet Little Lies
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  April (1)
    • ►  March (6)
    • ►  February (6)
    • ►  January (7)
  • ►  2011 (34)
    • ►  November (2)
    • ►  October (2)
    • ►  August (5)
    • ►  July (1)
    • ►  June (3)
    • ►  May (5)
    • ►  March (4)
    • ►  February (2)
    • ►  January (10)
  • ►  2010 (124)
    • ►  December (19)
    • ►  November (11)
    • ►  October (12)
    • ►  September (9)
    • ►  August (16)
    • ►  July (8)
    • ►  June (14)
    • ►  May (21)
    • ►  April (3)
    • ►  March (6)
    • ►  February (5)
  • ►  2009 (9)
    • ►  December (9)

Labels

Wells Fargo (13) Rodman (10) HbA1C (8) afrezza (8) Bank of America (7) Al Mann (6) FDA (5) Mannkind (5) Hapoalim (4) Oppenheimer (4) Griffin (3) JP Morgan (3) Leerink (3) Renshaw (3) Research analyst (3) TI (3) CRT (2) Comparison of Exubera and Afresa (2) Diabetologists (2) Early intervention (2) JMP (2) Joshua Schimmer (2) Piper Jaffray (2) Technosphere (2) first phase insulin release (2) hypos (2) titration (2) Approval (1) Baird (1) Comments (1) Cramer (1) Guest contributor (1) Heinemann (1) Morgan Stanley (1) PPG (1) Pulmonary Delivery (1) Real users (1) Shorts (1) Transcripts (1) Valuation (1) eAG (1) earnings conference call summary (1) interview (1)

Links I like

  • KLLJ blog
  • Robert S. Horn Medbio

Yahoo !

Google Mannkind feed

Loading...
 

Mannkind's products

Mannkind's products